Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Information Update - Certain hand sanitizers recalled because they may pose health risks


OTTAWA, ON, Aug. 24, 2021 /CNW/ - Health Canada is advising Canadians that the following hand sanitizers are being recalled because they may pose health risks. For more information, including what Canadians should do, visit the online safety alert.

Health Canada maintains this list of hand sanitizers that may pose health risks, so that Canadians can easily identify products they may have purchased and take appropriate action. Canadians are encouraged to check it regularly for updates.

Product

Reason for recall

Company

NPN or DIN

Lot Number(s)

Expiry Date

Avalon Laboratories - Ethanol Hand Sanitizer 80%; Securol Hand Sanitizer

Contains undeclared impurity, acetaldehyde, at elevated levels

Avalon Laboratories

80101239

E062220C

E062320B

E070920A

E071420C

E071720A

E072320A

E072420C

E080420A

E081020A

E121620A

June 2022

June 2022

July 2022

July 2022

July 2022

July 2022

July 2022

August 2022

August 2022

December 2022

Hand San 510D

Contains undeclared impurity, acetaldehyde, at elevated levels; not properly labelled (including missing information for vulnerable population and missing all information in French)

DuBois Chemicals Canada, Inc.

80098648

All

All

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 09:00
Dental Care Acworth is thrilled to utilize this remarkable innovation and offer patients unbiased, objective and standardized dental care that they know they can trust. The AI solutions Pearl delivers can assist dental...

at 09:00
Tolland Hill Family Dental is thrilled to announce the addition of Dr. Conway Ma to its esteemed team of dental professionals. Tolland Hill Family Dental offers a wide range of services, catering to patients of all ages. From a child's first dental...

at 09:00
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...

at 09:00
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for RAG-01, a...

at 09:00
Arbele, a clinical-stage biotechnology company focused...

at 08:53
Alera Health, a leader in population health management integrating behavioral healthcare, is proud to announce its recognition as one of the Great Employers to Work for in North Carolina by Best Companies Group. The 2024 Great Employers to Work for...



News published on and distributed by: